Price-to-Projected Revenue Ratio: Empro Group Inc. (EMPG)

Empro Corporation (EMPG) - corporate logo

The growth of Empro Group Inc (EMPG) relies on the success of new dermatological developments and recognition from aesthetic specialists. The expected P/S metric is available in the GURU.Markets system, where the indicator remains around 0.00. Malaysian management is only beginning to establish governance transparency, while aggressive marketing and pricing pressure in the pharmacy sector seriously limit the business's current profitability.

EMPG Empro Group: Forward Price to Sales in the range 07/03/2025 - 07/04/2025

Comprehensive metric breakdowns and analytics for Empro Corporation (EMPG)

- market price and analyst price targets:
Price Chart Empro Group|EMPG - Consensus Target
- company stock exchange capitalization indicators:
Market Value Empro Corporation|EMPG - Full Business Value
- book value of equity indicators:
Net Assets per Single Share Empro Group|EMPG - Accounting Value of Company|Market Value to Book Value Ratio empro.my|EMPG - Company Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Empro Group Inc|EMPG - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Empro Group Inc|EMPG - Company Total Indebtedness|Debt to Book Capitalization Ratio Empro Corporation|EMPG - Company Long-Term Loans and Borrowings|Company Short-Term Debt Empro Group|Quick Liquidity Indicator empro.my
- business earnings and investment ratios data:
EMPG - Net Profit|Expected Profit Empro Group Inc|EMPG - Market Cap to Net Income|Projected Price to Earnings Empro|EMPG - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Empro Corporation|EMPG - Operating income before deduction of amortization|Earnings per share for the last twelve months Empro Group|EMPG - Earnings per share for the last 12 months|Quarterly EPS earnings growth empro.my|EMPG - Net earnings per share growth this year|Earnings growth forecast for next year Empro Group Inc
- company sales and revenue statistics:
EMPG - Company Total Revenue|Company Projected Revenue Empro Group|EMPG - Market Cap to Revenue|Price-to-Projected Revenue Ratio Empro Corporation
Basic company analysis:EMPG (Empro Group)
Manufactured products of Empro Corporation

The forward P/S ratio assesses the market value of Empro Group Inc (EMPG) relative to expected revenue, allowing investors to neutralize short-term volatility and focus on the long-term capitalization trend. Analysis of the forward P/S indicator reflects market expectations for the expansion of premium cosmetics distribution for Empro Group Inc (EMPG), where growth in this metric confirms a bet on marketing efficiency and brand recognition.

Key competitors

Price-to-Projected Revenue Ratio Krystal Biotech KRYS|APGE - Forward Price-to-Revenue Multiple|ARQT - Price-to-Projected Revenue Ratio|Future Price to Revenue VCEL|Oruka Therapeutics Inc (ORKA) - Price-to-Projected Revenue Ratio|Sanara MedTech - Forward Price to Sales|Price-to-Projected Revenue Ratio DBV Tech|Market Cap to Future Revenue Ratio Solesence Inc. SLSN|Forward Price-to-Revenue Multiple DERM (Journey Medical)|FBRX (Forte Biosciences Inc) - Forward Price to Sales|Forward P/S Multiple SLGL (Sol-Gel Technologies)|Projected Price to Revenue AXIL Brands Inc|MDCX - Price-to-Projected Revenue Ratio|Forward Price to Sales VRCA (Verrica Pharmaceuticals)|hoththerapeutics.com (HOTH) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Biofrontera (BFRI)|Forward Price-to-Revenue Multiple VYNE|Forward P/S Multiple Sonoma Pharma|Price-to-Projected Revenue Ratio Quoin Pharmaceuticals (QNRX)|AZTR: Future Price to Revenue|Dermata - Forward Price-to-Revenue Multiple|Forward Price to Sales ELAB|Revance Therapeutics - Forward P/S Multiple